Dr. Timo Strattner, an accomplished and versatile financial expert who leads Strattners as the Group CEO and Chief Investment Officer. Renowned for his exceptional achievements as a merchant banker and private fund manager, Dr. Strattner has garnered distinctions for his value-driven transactions in both primary and secondary capital markets.

Throughout his career, Dr. Strattner has held senior management roles of Listed Entities. His strategic accomplishments and drive to create opportunities have led to several landmark achievements, including spearheading a remarkable $1.5 Billion IPO in Australia, the largest of its kind for an Irish Real Estate Groupa. As an interim CEO, he played a pivotal role in launching the alternative immunotherapy division of Affinity Medical, showcasing his versatile leadership skills.

Moreover, Dr. Strattner’s expertise extends to the art of capitalization strategies. He skillfully orchestrated the securing of capital for a Hong Kong-Mexican based social housing construction partnership as the lead project manager, further solidifying his reputation as a value-added manager.

In his early years at the age of 14 he was accepted on a youth scholarship for music through the University of Arts in Bremen and later decided to continue his education into business. A lifelong learner, Dr. Strattner holds both a Bachelor’s degree and a Doctorate in Business Administration (DBA). His dedication to continuous education reflects his commitment to staying at the forefront of industry advancements, driving innovation, and delivering exceptional outcomes for his clients. With a career punctuated by excellence and a reputation as a visionary financier, Dr. Timo Strattner stands as a leading figure in the financial world, making profound contributions to the growth and success of the organizations he serves.